119 related articles for article (PubMed ID: 2456800)
1. The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascade.
Burdach S; Shatsky M; Wagenhorst B; Levitt L
Blood; 1988 Aug; 72(2):770-5. PubMed ID: 2456800
[TBL] [Abstract][Full Text] [Related]
2. Receptor-specific inhibition of bone marrow erythropoiesis by recombinant DNA-derived interleukin-2.
Burdach SE; Levitt LJ
Blood; 1987 May; 69(5):1368-75. PubMed ID: 3105620
[TBL] [Abstract][Full Text] [Related]
3. T cell regulated hematopoiesis--molecular interactions in hematopoietic control by CD2 and interleukin 2.
Burdach S; Levitt L
Behring Inst Mitt; 1988 Aug; (83):56-67. PubMed ID: 2907289
[TBL] [Abstract][Full Text] [Related]
4. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor-independent CD2 signal transduction in FcR+ cells.
Arulanandam AR; Koyasu S; Reinherz EL
J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
[TBL] [Abstract][Full Text] [Related]
7. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2.
Burdach S; Shatsky M; Wagenhorst B; Levitt L
J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272
[TBL] [Abstract][Full Text] [Related]
8. [Lymphokine-induced suppression of erythropoiesis by normal T lymphocytes and retrovirus-associated lymphoproliferative disease].
Burdach S; Levitt L; Wahn V; Göbel U
Onkologie; 1989 Jun; 12(3):116-9. PubMed ID: 2548140
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.
Chong AS; Staren ED; Scuderi P
Cancer Immunol Immunother; 1992; 35(5):335-41. PubMed ID: 1382856
[TBL] [Abstract][Full Text] [Related]
10. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA
J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968
[TBL] [Abstract][Full Text] [Related]
11. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
12. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
Kanner SB; Damle NK; Blake J; Aruffo A; Ledbetter JA
J Immunol; 1992 Apr; 148(7):2023-9. PubMed ID: 1372020
[TBL] [Abstract][Full Text] [Related]
13. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
[TBL] [Abstract][Full Text] [Related]
14. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
15. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.
Moingeon P; Lucich JL; McConkey DJ; Letourneur F; Malissen B; Kochan J; Chang HC; Rodewald HR; Reinherz EL
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1492-6. PubMed ID: 1346934
[TBL] [Abstract][Full Text] [Related]
16. Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation.
Anderson P; Blue ML; Morimoto C; Schlossman SF
Cell Immunol; 1988 Sep; 115(2):246-56. PubMed ID: 2900689
[TBL] [Abstract][Full Text] [Related]
17. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
18. Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: dependence upon the individual anti-CD3 monoclonal antibody used for activation.
Stohl W; Posnett DN; Chiorazzi N
Cell Immunol; 1988 Oct; 116(1):73-85. PubMed ID: 2458845
[TBL] [Abstract][Full Text] [Related]
19. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
Ocklind G
Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
[TBL] [Abstract][Full Text] [Related]
20. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2.
Endler-Jobst B; Schraven B; Hutmacher B; Meuer SC
J Immunol; 1991 Mar; 146(6):1736-42. PubMed ID: 1706379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
